News

The Phase 2 trial will assess the anti-tumor activity, tolerability and safety of retaspimycin HCl in combination with docetaxel as compared to docetaxel alone in approximately 100 second-

UST claims its PBV process technology makes it possible to achieve higher yields after drying and better stability during storage at ambient or even higher temperatures (including 37°C

The main objective of the trial is to assess the safety and tolerability of VP 20621 dosed orally for up to 14 days in adults previously treated for

Veeva CRM allows to manage customer information and interactions and features quick deployment, ease of use, cost efficiency and scalability. Veeva said its CRM application requires no hardware

Ulipristal acetate is an orally active selective progesterone receptor modulator that reversibly blocks the progesterone receptors in targeted tissues. It is marketed as ellaOne in Europe as well

The company has developed the anti malarial drug by utilizing its Dose Optimization Technology under the Novel Drug Delivery System (NDDS). ARH 1 carries Arteether 150mg/ml and is

Under the agreement, Unigene is expected utilize its peptide manufacturing technology to offer clinical supply material for a Phase 3 study of experimental drug CR845, to be conducted

The milestone payment triggers from the initiation of a Phase 1 clinical trial of ISIS-TTRRx, an antisense drug, by Isis Pharma to treat transthyretin amyloidosis. The agreement allows

The company expects to recruit around 880 patients in 48 hospitals in 9 countries across three continents. The study, named as immunotherapy Multikine anti tumor treatments (IT-MATTERS), is